Cradle Bio B.V.

About Cradle Bio B.V.

Cradle Bio develops AI software that helps biologists design improved proteins and microorganisms. Its platform combines generative machine-learning models with wet-lab automation to predict mutations, guide experimental cycles, and accelerate R&D for enzymes, vaccines, and therapeutic proteins. The company serves pharmaceutical, chemical, and food-industry customers, reducing development timelines and costs compared to traditional directed-evolution methods. Headquartered in Delft, Netherlands, with additional operations in Zurich, Cradle Bio was founded in 2021 and operates as a privately held venture-backed entity.